- In December 2023, Perrigo Company plc expanded its generic OTC expectorant portfolio across North America and Europe, focusing on guaifenesin-based formulations for both pediatric and adult markets. The launch includes sugar-free variants and extended-release tablets to cater to changing consumer preferences. This move aligns with the growing consumer trend toward accessible and cost-effective cough and cold treatments
- In October 2023, Dr. Reddy’s Laboratories introduced a new line of herbal-based expectorants in the Indian market under its “NATURZ” range. These products include plant-based ingredients such as tulsi and mulethi, reflecting rising demand for natural alternatives to synthetic drugs. The company aims to capture growing interest in herbal and Ayurvedic formulations for respiratory conditions
- In August 2023, Genexa Inc., a U.S.-based clean medicine company, launched its reformulated organic children’s expectorant syrup made without artificial dyes, parabens, or high-fructose corn syrup. Marketed toward health-conscious parents, this product aims to provide safer, more transparent options in the pediatric OTC medication segment
